Selbyville, Delaware, Sept. 23, 2024 (GLOBE NEWSWIRE) --
Tuberculosis Diagnostics Test Market size will reach USD 3.7 Billion by 2032. Technological advancements in tuberculosis diagnostics are significantly enhancing industry progression by improving the accuracy and efficiency of disease detection.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/7892
Molecular diagnostics, such as nucleic acid amplification tests (NAATs), and innovations such as GeneXpert have revolutionized TB testing by providing rapid and reliable results. These technologies reduce the time required for diagnosis, enabling earlier treatment and better patient outcomes. The Global Fund noted that in 2024, investments in new TB diagnostic technologies, including GeneXpert and other molecular tests, have increased by 30% compared to the previous year.
Additionally, the development of rapid point-of-care tests allows for TB detection in resource-limited settings, further expanding access to diagnostics. As these technologies continue to evolve, they play a crucial role in ushering in the global market.
Radiographic test to gain popularity for TB detection
The tuberculosis diagnostics test market from radiographic segment will grow rapidly during the forecast period, due to their effectiveness in detecting TB, particularly in patients with non-specific or asymptomatic presentations. Radiographic techniques, such as chest X-rays, are increasingly utilized in large-scale screening programs, especially in high-risk populations. These methods provide a non-invasive and relatively quick way to identify pulmonary TB, aiding in early diagnosis and intervention. Additionally, advancements in digital radiography are improving image quality and diagnostic accuracy, further boosting their adoption in TB detection efforts worldwide.
POCT adoption to address tb burden in remote communities
The tuberculosis diagnostics test market from point-of-care testing (POCT) segment will witness decent development between 2024 to 2032, owing to the growing need for rapid and accessible testing in remote and resource-limited areas. POCT enables immediate diagnosis and treatment decisions, significantly reducing the time between testing and care. This is particularly critical in regions with limited laboratory infrastructure where traditional testing methods are less feasible. Furthermore, POCT supports large-scale screening efforts by providing quick results, which is essential for controlling TB spread in high-burden communities.
Resurgence of TB boosts diagnostic demand in Europe
Europe tuberculosis diagnostics test market size will expand at a notable pace through 2032, because of a resurgence of TB cases, particularly among vulnerable populations such as immigrants, refugees, and those with compromised immune systems. Increased efforts by European health authorities to achieve early detection and treatment are driving the need for advanced diagnostic tools. Additionally, the rising incidence of multidrug-resistant TB (MDR-TB) in the region is prompting the adoption of more accurate and timely diagnostics. Public health initiatives and funding aimed at eradicating TB further support the expansion of diagnostic services across Europe.
Request for Report Customization @ https://www.gminsights.com/roc/7892
Tuberculosis Diagnostics Test Market Players
Major players in the tuberculosis diagnostics test industry include Abbott Laboratories, Becton, Dickinson and Company (BD), bioMerieux SA, Cepheid (Danaher Corporation), F. Hoffmann-La Roche Ltd., Hologic, Inc., Hain Lifescience GmbH, Oxford Immunotec (PerkinElmer), Qiagen N.V., Roche Molecular Systems Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
In February 2023, Thermo Fisher Scientific launched real-time PCR kits in India for detecting a range of infectious diseases, including Multi-Drug-Resistant Tuberculosis (MTB MDR) and HIV. Approved by the Central Drugs Standard Control Organization (CDSCO) and produced with Mylab Discovery Solutions, these kits boost the company’s market presence and revenue in India.
Partial Table of Contents (ToC) of the report:
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Base estimates and working
1.3 Forecast calculations
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global tuberculosis diagnostics test market 3600 synopsis, 2018 – 2032
2.1.1 Regional trends
2.1.2 Test type trends
2.1.3 End-use trends
Chapter 3 Tuberculosis Diagnostics Test Industry Insights
3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Rising burden of tuberculosis globally
3.4.1.2 Advancement in tuberculosis diagnostics techniques
3.4.1.3 Increasing awareness and screening programs regarding tuberculosis
3.4.1.4 Surge in Point-of-Care testing (POCT)
3.4.2 Industry pitfalls and challenges
3.4.2.1 Limited sensitivity and specificity
3.4.2.2 Stringent regulatory scenario
3.5 Growth potential analysis
3.5.1 By test type
3.5.2 By end-use
3.6 Porter's analysis
3.7 PESTEL analysis
Browse more diagnostic devices industry reports @ https://www.gminsights.com/industry-reports/diagnostic-devices/82
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
